In Cancer’s Genes

Authors

Keywords:

breast cancer, genetic, genetic medicine, personalized medicine, health technology

Abstract

Professor Børresen-Dale is a pioneer in gene-based cancer treatment. By decoding the genetic material of a patient’ s tumor, researchers can determine the tumor’s “Achilles’ heel,” its weak point, and thus the optimal treatment. This approach is known as “ personalized treatment” and may eventually lead to “personalized prevention,” whereby researchers are able to foresee genetic dispositions towards particular diseases and prevent them from occuring. Hand in hand with her ge- netic research work, Professor Børresen-Dale works as an avid advocate for the development of translational sciences. Translational science refers to the concept of converting results from basic research into applied research and product devel- opment, also described as translating bench science into bedside clinical practice. With personalized treatment potentially redefining our approach and experience in breast cancer research, we asked Pr. Børresen-Dale ten questions about the future of breast cancer.

Downloads

Published

2011-05-31

How to Cite

Helle, P. (2011). In Cancer’s Genes. McGill Journal of Global Health, 1(1), 39–44. Retrieved from https://mjgh.library.mcgill.ca/article/view/1213